WALTHAM, Mass. – Fresenius Medical Care North America (FMCNA), a division of Fresenius Medical Care (NYSE: FMS) and North America’s largest provider of kidney care, hospitalist services and renal products, announced today the release of its 2015 Annual Medical Quality Report (AMQR).
The 2015 AMQR offers an overview of FMCNA’s coordinated care efforts through its portfolio of core and new health business assets, as well as clinical highlights leading up to 2015 across the full spectrum of its health enterprise. This includes the evolution of services and therapies that continue to improve the health outcomes of patients with chronic care needs and reduce costs to manage their care.
“Our efforts in 2015 focus on enhancing our ability to coordinate health care in multiple venues, so patients with chronic illness can receive the care they need where and when they need it most,” said Dr. Frank Maddux, Chief Medical Officer of Fresenius Medical Care North America. “By developing strong bonds between patients and providers across the clinical care continuum, we can improve patients’ lives and avoid consequences from their known chronic illnesses. This year’s Annual Medical Quality Report reflects what we have accomplished and what we are doing to achieve our primary goal of improving the quality of life for patients under our care.”
The 2015 Annual Medical Quality Report can be found on FMCNA’S newly redesigned corporate website or download at: www.freseniusmedicalcare.us/fileadmin/data/us/Media_Center/FMCNA-AMQR-2015.pdf.
About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier health care company focused on delivering the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, as well as the country’s largest practice of hospitalist and post-acute providers, Fresenius Medical Care provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s only vertically integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at www.freseniusmedicalcare.us.